{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:37:59Z","timestamp":1791999479244,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.hfc.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T17:09:53Z","timestamp":1573751393000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Hypertension and Heart Failure"],"prefix":"10.1016","volume":"16","author":[{"given":"Katherine E.","family":"Di Palo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.hfc.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.hfc.2019.09.001_bib2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"24","key":"10.1016\/j.hfc.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mcna.2016.08.012","article-title":"Heart failure and hypertension: importance of prevention","volume":"101","author":"Pfeffer","year":"2017","journal-title":"Med Clin North Am"},{"issue":"16","key":"10.1016\/j.hfc.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.1996.00440150033003","article-title":"The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview","volume":"156","author":"Vasan","year":"1996","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.hfc.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12170-011-0184-2","article-title":"Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma","volume":"5","author":"Bhuiyan","year":"2011","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"21","key":"10.1016\/j.hfc.2019.09.001_bib8","first-page":"e393","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon Mercedes","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hfc.2019.09.001_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2008.12.037","article-title":"Heart failure in Hispanics","volume":"53","author":"Vivo","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.294.4.466","article-title":"Hypertension in adults across the age spectrum: current outcomes and control in the community","volume":"294","author":"Lloyd-Jones","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hfc.2019.09.001_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.hfc.2019.09.001_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.22917","article-title":"Sex differences in heart failure","volume":"41","author":"Eisenberg","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hfc.2019.09.001_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.hfc.2019.06.005","article-title":"The evolution from hypertension to heart failure","volume":"15","author":"Sorrentino","year":"2019","journal-title":"Heart Fail Clin"},{"issue":"7","key":"10.1016\/j.hfc.2019.09.001_bib16","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/0735-1097(92)90617-V","article-title":"Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension","volume":"19","author":"Ganau","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2019.09.001_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10741-007-9060-z","article-title":"Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies","volume":"13","author":"Wright","year":"2008","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","article-title":"Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study","volume":"29","author":"de Simone","year":"2008","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.hfc.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.hfc.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00004872-200306000-00002","article-title":"Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003","volume":"21","author":"Staessen","year":"2003","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/eurheartj\/ehn575","article-title":"Blood pressure reduction and renin\u2013angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis","volume":"30","author":"Verdecchia","year":"2009","journal-title":"Eur Heart J"},{"issue":"10022","key":"10.1016\/j.hfc.2019.09.001_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.hfc.2019.09.001_bib25","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.HYP.34.6.1181","article-title":"J-shaped relation between blood pressure and stroke in treated hypertensives","volume":"34","author":"Vok\u00f3","year":"1999","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1991.03460040065031","article-title":"The J-curve phenomenon and the treatment of hypertension: is there a point beyond which pressure reduction is dangerous?","volume":"265","author":"Farnett","year":"1991","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hfc.2019.09.001_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11906-012-0314-3","article-title":"Blood pressure j-curve: current concepts","volume":"14","author":"Banach","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.hfc.2019.09.001_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjcard.2010.02.032","article-title":"Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial)","volume":"106","author":"Desai","year":"2010","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamacardio.2017.5365","article-title":"Systolic blood pressure and outcomes in patients with heart failure with preserved ejection fraction","volume":"3","author":"Tsimploulis","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2019.09.001_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/heartjnl-2018-314438","article-title":"Management of blood pressure in heart failure","volume":"105","author":"Pinho-Gomes","year":"2019","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.hfc.2019.09.001_bib33","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/CIRCULATIONAHA.105.544031","article-title":"Role of diuretics in the prevention of heart failure: the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"113","author":"Davis","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2019.09.001_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.91.3.698","article-title":"Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)","volume":"91","author":"Liebson","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2019.09.001_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hfc.2019.09.001_bib36","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.109.865774","volume":"120","author":"Verdecchia","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2019.09.001_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Investigators*","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"30","key":"10.1016\/j.hfc.2019.09.001_bib38","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi","year":"2015","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.hfc.2019.09.001_bib39","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2019.09.001_bib40","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hfc.2019.09.001_bib41","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2019.09.001_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.70.1.63","article-title":"Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial","volume":"70","author":"Franciosa","year":"1984","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jchf.2013.04.004","article-title":"Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2019.09.001_bib44","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hfc.2019.09.001_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1388-9842(03)00163-6","article-title":"Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)","volume":"5","author":"Cohn","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2019.09.001_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE.114.001104","article-title":"Incidence, predictors, and outcomes related to hypo-and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist","volume":"7","author":"Vardeny","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2019.09.001_bib47","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2165\/11631100-000000000-00000","article-title":"Heart failure in hypertension: prevention and treatment","volume":"72","author":"Georgiopoulou","year":"2012","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.hfc.2019.09.001_bib48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jash.2014.02.003","article-title":"Blood pressure effects of sodium\u2013glucose co-transport 2 (SGLT2) inhibitors","volume":"8","author":"Oliva","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:39:49Z","timestamp":1761554389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713619300996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1551713619300996"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2019.09.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension and Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}